Radiopharm Theranostics RADX

Lantheus Omega reports a 20.9% stake in Radiopharm Theranostics

Form
Schedule 13D
Filed
Importance
Notable

Not explained yet; the original is on EDGAR.

Ownership stake disclosure by Lantheus Holdings, Inc.

Get an email when Radiopharm Theranostics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float not reported.